Mast cells mediate complement activation after acid aspiration

Shock

Volumn 16, Issue 1, 2001, Pages 21-24

  Kyriakides, Constantinos ^a,b   Austen Jr , William G ^a,b   Wang, Yong ^a,b   Favuzza, Joanne ^a,b   Kobzik, Lester ^a   Moore Jr , Francis D ^a,b   Hechtman, Herbert B ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chymase; Granulocytes; Inflammation; Pneumonia; Substance P; Transgenic mice

Indexed keywords

CHYMASE; CHYMOSTATIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; OLIGOPEPTIDE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SUBSTANCE P;

ANIMAL; ARTICLE; ASPIRATION PNEUMONIA; COMPLEMENT ALTERNATIVE PATHWAY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MALE; MAST CELL; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CHYMASES; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT PATHWAY, ALTERNATIVE; MALE; MAST CELLS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OLIGOPEPTIDES; PNEUMONIA, ASPIRATION; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SUBSTANCE P;

EID: 0035405939     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200116010-00004     Document Type: Article

References (28)

1. Fowler AA, Hamman RF, Good JT, Benson KN, Vaird M, Eberle DJ, Petty TL, Hyers TM: Adult respiratory distress syndrome: risk with common predispositions. Ann Int Med 98:593-597, 1983.
2. Oisson GL, Hallen B, Hambraeus Jonzon K: Aspiration during anesthesia: a computer-aided study of 185,358 anesthetics. Acta Anaesthesiol Scand 30:84-92, 1986.
3. Kallar SK, Everett LL: Potential risks and preventative measure for pulmonary aspiration: new concepts in preventative fasting guidelines. Anesth Analg 77: 171-182, 1993.
4. Utsunomiya T, Krausz M, Dunham B, Valeri CR, Shepro D, Hechtman HB: Modification of inflammatory response to aspiration with ibuprofen. Am J Physiol 243:H903-H910, 1982.
5. Pepe, PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ: Clinical predictors of adult respiratory distress syndrome. Am J Surg 144:124-130, 1982.
6. Kennedy TP, Johnson KJ, Kunkel RG, Ward PA, Knight PR, Finch JS: Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesth Analg 69:87-92, 1989.
7. Weiser MR, Pechet TT, Williams JP, Ma M, Frenette PS, Moore Jr. FD, Kobzik L, Hines RO, Wagner DD, Carroll MC, Hechtman HB: Experimental murine acid aspiration injury is mediated by neutrophils and the alternative complement pathway. J Appl Physiol 83:1090-1095, 1997.
8. Kyriakides C, Austen W Jr, Wang Y, Favuzza J, Kobzik L, Moore FD Jr, Hechtman HB: Membrane attack complex of complement and neutrophils mediate the injury of acid aspiration. J Appl Physiol 87:2357-2361, 1999.
9. Müller-Ebenhard HJ: Molecular organization and function of the complement system. Ann Rev Biochem 57:321-347, 1988
10. Marks RM, Todd III RF, Ward PA: Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature 339:314-317, 1989.
11. Halperin JA, Taratuska A, Runkiewicz M, Nicholson-Weller A: Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). Blood 81:200-205, 1993.
12. He S, Walls AF: The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol 352:91-98, 1998.
13. Kiernan JA: Degranulation of mast cells in the trachea and bronchi of the rat following stimulation of the vagus nerve. Int Arch Allergy Appl Immunol 91: 398-402, 1990.
14. d mice: their value for the analysis of the roles of mast cells in biologic response in vivo. Am J Physiol 127:191-198, 1987.
15. He S, Walls AF: Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 125: 1491-1500, 1998.
16. 7,9-substance P. Neuropharmacology 22:1397-1400, 1983.
17. Dewaal RMW, Schrijver G, Bogman MJJT, Assmann KJM, Koene AP: An improved sensitive and simple microassay of mouse complement. J Immunol Meth 108:213-221, 1988.
18. Klerx JP, Beukelman CJ, Van Dijk H, Willers JMN: Microassay for colorimetric estimation of complement activity in guinea pig, human, and mouse serum. J Immunol Meth 63:215-220, 1983.
19. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, StamLer JS: Nitric oxide synthase in human and rat lung: immunohistochemical and histological localization. Am J Respir Cell Mol Biol 9:371-377, 1993.
20. Barrett KE, Metcalfe DD: Mast cell heterogeneity: evidence and implications. J Clin Immunol 4:253-261, 1982.
21. Irani AA, Schlechter NM, Craig SS, DeBlois G, Schwartz LB: Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 83:4464-4468, 1986.
22. Roxvall L, Bengson A, Sennerby L, Heideman M: Activation of the complement cascade by trypsin. Biol Chem Hoppe Seyer 372:273-278, 1991.
23. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF: Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem 272:7127-7131, 1997.
24. 84 bond by mast cell chymase. J Biol Chem 269:18134-18140, 1994.
25. Rother U: Shock and shock fragments. In Rother K, Till GO (eds). The complement system. Berlin: Springer-Verlag, 1988, pp 505.
26. Briggaman RA, Schechter NM, Fräki JE, Lazarus GS: Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 160:1027-1042, 1984.
27. Bienenstock J, Perdue M, Blennerhassett M, Stead R, Kakuta N, Sentini P, Vancheri C, Marshall J: Inflammatory cells and the epithelium. Mast cell/nerve interactions in the lung in vitro and in vivo. Am Rev Respir Dis 138:S31-S34, 1988.
28. Sertl K, Wiedermann CJ, Kowalski ML, Hurtado S, Plutchok J, Linnoila I, Pert CB, Kaliner MA: Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability. Am Rev Respir Dis 138:151-159, 1988.